CENTERCROSS

WIPO WIPO 2018

Protect this trademark from copycats!

With our trademark monitoring alerts, you are automatically notified by email about copycats and free riders.

The International trademark CENTERCROSS was filed as Word mark on 03/08/2018 at the World Intellectual Property Organization.

Trademark Details Last update: February 24, 2023

Trademark form Word mark
File reference 1426604
Countries Australia Switzerland China European Community United Kingdom Mexico Norway New Zealand Serbia Turkey
Base trademark US No. 87824811, March 7, 2018
Application date March 8, 2018
Expiration date October 11, 2021

Trademark owner

400 Seaport Court,
Suite 103
US

Trademark representatives

Seventh Floor Offices Artillery House GB

goods and services

10 Surgical and medical apparatus, instruments and devices for use in the prevention and treatment of circulatory system issues and conditions; surgical and medical apparatus, instruments and devices for use in the prevention and treatment of pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, intracranial haemorrhages, cerebral haemorrhages, hematomas, peripheral vascular lesions, and coronary vascular lesions; medical and surgical catheters for use in the prevention and treatment of circulatory system issues and conditions; medical and surgical catheters for use in the prevention and treatment of pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusions, blood clots, vascular issues and conditions, intracranial haemorrhages, cerebral haemorrhages, hematomas, peripheral vascular lesions, and coronary vascular lesions; catheters and microcatheters; parts and fittings for all the aforesaid goods
41 Education services, namely, developing, arranging and conducting educational programmes and providing courses of instruction in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in the fields of the prevention and treatment of circulatory system issues and conditions, namely, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, intracranial haemorrhages, cerebral haemorrhages, hematomas, peripheral vascular lesions, and coronary vascular lesions, and distribution of course material in connection therewith; training in the use and operation of medical devices and medical research apparatus and consultation relating thereto; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions, and training programs in the fields of health care and medical diseases, disorders and related treatments and in the fields of the prevention and treatment of circulatory system issues and conditions, namely, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, intracranial haemorrhages, cerebral haemorrhages, hematomas, peripheral vascular lesions, and coronary vascular lesions, and distribution of course material in connection therewith; educational services, namely, providing non-downloadable webinars in the fields of health care and medical diseases, disorders and related treatments in relation to the prevention and treatment of circulatory system issues and conditions, namely, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, intracranial haemorrhages, cerebral haemorrhages, hematomas, peripheral vascular lesions, and coronary vascular lesions, and distribution of course material in connection therewith; provision of educational content, namely, providing on-line instruction in the fields of health care and medical diseases, disorders and related treatments in relation to the prevention and treatment of circulatory system issues and conditions, namely, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, intracranial haemorrhages, cerebral haemorrhages, hematomas, peripheral vascular lesions, and coronary vascular lesions, and distribution of course material in connection therewith; providing information about medical education in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and patient care via computer, electronic and on-line databases; advisory services in the field of medical education; educational services, namely, conducting live and online seminars, classes, workshops, lectures, panel discussions and training in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine; educational services, namely, providing non-downloadable webinars in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine and distribution of course material in connection therewith; providing non-downloadable electronic publications in the nature of teaching guides, instructional materials, brochures, and course books in the fields of healthcare, the use of pharmaceuticals and medical devices, medical research, surgery, medical science, medicine and in relation to the prevention and treatment of circulatory system issues and conditions, namely, pulmonary embolisms, thrombus, deep vein thrombosis, peripheral arterial occlusion, blood clots, vascular issues and conditions, intracranial haemorrhages, cerebral haemorrhages, hematomas, peripheral vascular lesions, and coronary vascular lesions; providing information about medical education in the fields of healthcare, pharmaceuticals, medical devices, medical research, surgery, medical science and medicine via electronic online databases

Trademark history

Date Document number Area Entry
June 7, 2022 2022/28 Gaz US RAW: Total Ceasing Effect
September 29, 2021 2021/43 Gaz MX RAW: Rule 18ter(2)(ii) GP following a provisional refusal
February 21, 2020 2020/9 Gaz MX Rejection
September 27, 2019 2019/40 Gaz NO Rejection
September 23, 2019 2019/39 Gaz CH Rejection
May 23, 2019 2019/21 Gaz AU Rejection
April 25, 2019 2019/17 Gaz RS Rejection
March 25, 2019 2019/13 Gaz TR Rejection
March 22, 2019 2019/12 Gaz NZ Rejection
March 6, 2019 2019/10 Gaz EM Rejection
February 25, 2019 2019/11 Gaz CN Rejection
January 9, 2019 2019/2 Gaz GB Rejection
March 8, 2018 2018/38 Gaz US Registration

ID: 141426604